Sustainable Business
Secretive ‘Rebate Trap’ in US Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
Rebate trap joins a long history of efforts by makers of brand-name drugs to stifle generics, including protecting drugs with multiple layers of dubious patents, “pay for delay”...
